DELL'ERA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 9.415
EU - Europa 4.024
AS - Asia 3.764
SA - Sud America 533
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 87
OC - Oceania 30
Totale 18.116
Nazione #
US - Stati Uniti d'America 9.251
CN - Cina 1.376
PL - Polonia 1.353
SG - Singapore 1.231
UA - Ucraina 644
DE - Germania 465
BR - Brasile 433
IT - Italia 400
HK - Hong Kong 390
GB - Regno Unito 248
FI - Finlandia 245
VN - Vietnam 215
FR - Francia 201
IN - India 136
RU - Federazione Russa 130
TR - Turchia 119
IE - Irlanda 109
CA - Canada 92
BD - Bangladesh 81
ES - Italia 42
AR - Argentina 41
NL - Olanda 40
ID - Indonesia 34
MX - Messico 34
CZ - Repubblica Ceca 33
JP - Giappone 30
SE - Svezia 30
ZA - Sudafrica 28
AU - Australia 27
BE - Belgio 25
IQ - Iraq 20
EC - Ecuador 17
CO - Colombia 15
PK - Pakistan 14
SA - Arabia Saudita 14
JM - Giamaica 13
MA - Marocco 12
TW - Taiwan 12
NG - Nigeria 11
UZ - Uzbekistan 11
VE - Venezuela 11
AT - Austria 10
EU - Europa 9
IR - Iran 9
CH - Svizzera 8
DZ - Algeria 8
KR - Corea 8
MY - Malesia 8
AZ - Azerbaigian 7
EE - Estonia 7
LT - Lituania 7
IL - Israele 6
KE - Kenya 6
KZ - Kazakistan 6
AE - Emirati Arabi Uniti 5
HN - Honduras 5
JO - Giordania 5
KG - Kirghizistan 5
BO - Bolivia 4
CL - Cile 4
EG - Egitto 4
PY - Paraguay 4
BG - Bulgaria 3
CR - Costa Rica 3
GR - Grecia 3
MD - Moldavia 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
SD - Sudan 3
TH - Thailandia 3
TN - Tunisia 3
AO - Angola 2
BB - Barbados 2
BZ - Belize 2
CI - Costa d'Avorio 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
MU - Mauritius 2
NP - Nepal 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
BH - Bahrain 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FJ - Figi 1
GT - Guatemala 1
IS - Islanda 1
LC - Santa Lucia 1
Totale 17.846
Città #
Warsaw 1.343
Fairfield 1.025
Ashburn 853
Woodbridge 797
Singapore 649
Houston 504
Jacksonville 477
San Jose 449
Cambridge 412
Seattle 400
Ann Arbor 394
Hong Kong 379
Wilmington 369
Chandler 289
Beijing 264
The Dalles 241
Princeton 202
Nanjing 173
Council Bluffs 163
Helsinki 152
New York 151
Los Angeles 130
Dublin 107
Brescia 102
Dallas 100
Chicago 98
Dearborn 95
Lauterbourg 90
Istanbul 87
Columbus 79
Munich 72
Buffalo 67
Dong Ket 62
Moscow 60
Santa Clara 59
Changsha 58
San Francisco 56
Shanghai 56
Ho Chi Minh City 53
Nanchang 53
Milan 52
São Paulo 52
Shenyang 43
Jinan 42
Des Moines 39
Phoenix 39
San Diego 39
Hebei 36
Orem 36
Redondo Beach 36
Lancaster 35
Tianjin 34
Jiaxing 32
Hanoi 30
Hangzhou 29
Manchester 28
Brooklyn 27
Chennai 26
Tokyo 26
Boardman 25
Brussels 25
London 25
Jakarta 23
Atlanta 22
Kunming 22
Tampa 22
Montreal 21
San Mateo 21
Taizhou 20
Brno 19
Denver 19
Salt Lake City 19
Amsterdam 18
Ningbo 18
Toronto 18
Guangzhou 17
Lanzhou 17
Augusta 16
Brasília 16
Stockholm 16
Elk Grove Village 15
Leawood 15
Miami 15
Mumbai 15
Vieste 15
Charlotte 14
Frankfurt am Main 14
Olomouc 14
Rome 14
Belo Horizonte 13
Haikou 13
Poplar 13
Turku 13
Zhengzhou 13
Boston 12
Mexico City 12
New Delhi 12
Seveso 12
Abuja 11
Barcelona 11
Totale 12.536
Nome #
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 417
Comparative analysis of mesenchymal stromal cells biological properties 358
Clinical potentials of human pluripotent stem cells 348
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 331
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a KCNA5 p.D322H mutation 329
Generation and characterization of human cardiomyocytes derived from pluripotent stem cells 327
Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation 316
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes 305
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 303
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation 300
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 285
Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System 280
Human derived cardiomyocytes: A decade of knowledge after the discovery of induced pluripotent stem cells 258
Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM 245
NOVEL GELATIN-BASED HYDROGELS FOR TISSUE ENGINEERING APPLICATION 232
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 231
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 221
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 220
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 218
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 218
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 215
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 211
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 205
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 201
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 198
Preparation and properties of high performance gelatin-based hydrogels with chitosan or hydroxyethyl cellulose for tissue engineering applications 197
Carbon on poly(ε-caprolactone) (PCL) ink-jet printed sensor for monitoring cell cultures of myoblasts 197
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 196
MEMS force microactuator with displacement sensing for mechanobiology experiments 194
Preliminary Study of Inkjet Printed Sensors for Monitoring Cell Cultures 194
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 193
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 193
Biomanufacturing of a Chitosan/Collagen Scaffold to Drive Adhesion and Alignment of Human Cardiomyocyte Derived from Stem Cells 190
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 187
Preparation and assessment of high performance gelatin-based hydrogels for tissue engineering 184
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 183
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 181
Ink-jet printed stretchable sensors for cell monitoring under mechanical stimuli: A feasibility study 179
Generazione di cardiomiociti umani per lo studio di patologie cardiovascolari 177
Increased frequency rate and alteration of If current in iPSC-derived atrial fibrillation human cardiomyocytes. 172
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 171
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 171
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 167
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. 167
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises 166
iPS, organoids and 3D models as advanced tools for in vitro toxicology 165
ELM: a new, simple, and economic assay to measure motility of lymphatic endothelial cells 165
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 163
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 163
Arrangement of live human cells through acoustic waves generated by piezoelectric actuators for tissue engineering applications 160
Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. 159
Prediction of abdominal aortic aneurysm calcification by means of variation of high-sensitivity C-reactive protein 158
Microstructured scaffold for guided cellular orientation: Poly(ε-caprolactone) electrospinning on laser ablated titanium collector 156
Using iPS cells toward the understanding of parkinson'€™s disease 156
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 156
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 156
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 155
Fibroblast growth factor-2 in angiogenesis 154
iPS technology as a tool to investigate atrial fibrillation. 153
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. 149
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 149
Preliminary report: hiPSC reprogramming and karyotypic studies 149
FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells. 148
iPSC-derived human cardiomyocytes from atrial fibrillation patients show increased frequency rate and alteration of If current 148
Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle. 148
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 147
Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. 145
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 144
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 142
Atrial fibrillation modeling with iPSC derived cardiomyocyte 140
Microsample stiffness MEMS sensor for on-chip mechanobiology experiments 140
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 139
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 139
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. 139
Differential expression of fibroblast growth factor receptors by human neurones, astrocytes and microglia. 139
Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy youngadults. 139
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 139
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 138
Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. 135
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 135
Patient-derived IPSC as a tool to unravel molecular determinants of familial atrial fibrillation 134
Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin. 132
Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. 129
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 126
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 123
Functional and biochemical characterization of induced Pluripotent Stem cells (iPSCs) from patients with Neutral Lipid Storage Disease with Myopathy 122
hiPSC reprogramming and karyotypic alterations: a brief report 121
iPS technology as a tool to investigate atrial fibrillation 118
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 116
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 115
Placental pericytes: the initial characterization shows similarities, as well as peculiar differences, with mesenchymal stem/stromal cells. 112
A detailed characterization of the hyperpolarization-activated “funny” current (If) in human-induced pluripotent stem cell (iPSC)–derived cardiomyocytes with pacemaker activity 112
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 111
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. 109
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 109
Role of FGFR1 in cardiovascular development:new insight from embryonic stem cells 105
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration 105
Characterization of subcutaneous and visceral fat derived mesenchymal stromal cells 94
Generation of the induced pluripotent stem cell line UNIBSi017-A from an individual with cardiospondylocarpofacial syndrome and the MAP3K7 c.737-7A > G variant. 86
Fat-derived mesenchymal stromal cells: different sources, different properties 85
Totale 17.905
Categoria #
all - tutte 73.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.379


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022663 0 0 0 17 10 56 51 57 41 133 72 226
2022/2023836 112 28 26 54 73 210 1 113 139 13 35 32
2023/2024838 57 21 95 42 43 111 32 38 205 19 27 148
2024/20252.047 26 19 5 280 180 185 158 48 266 132 521 227
2025/20264.138 394 471 303 519 545 305 637 130 291 330 144 69
2026/2027885 155 182 296 252 0 0 0 0 0 0 0 0
Totale 18.116